A-29.01, r. 2.1 - Regulation respecting exceptions to the prohibition against paying or reimbursing the price of a medication or supply covered by the basic prescription drug insurance plan

Section 2 Disposition versions

2021-04-15

2. Where a medication that was referred to in section 1 ceases to be referred to in that section, an accredited manufacturer or wholesaler or an intermediary may continue to pay or reimburse to a person covered by the basic prescription drug insurance plan all or part of the price of the medication for a maximum period of 30 days following the beginning of the application of the lowest price method to the medication or the entry of a generic or biosimilar version on the list drawn up by the Minister under section 60 of the Act, as the case may be.

M.O. 2021-014, s. 2.

Not in force

In force: 2021-04-15

2. Where a medication that was referred to in section 1 ceases to be referred to in that section, an accredited manufacturer or wholesaler or an intermediary may continue to pay or reimburse to a person covered by the basic prescription drug insurance plan all or part of the price of the medication for a maximum period of 30 days following the beginning of the application of the lowest price method to the medication or the entry of a generic or biosimilar version on the list drawn up by the Minister under section 60 of the Act, as the case may be.

M.O. 2021-014, s. 2.